EMD-22894
SARS-CoV-2 Spike Glycoprotein, prefusion with one RBD up conformation
EMD-22894
Single-particle3.6 Å
Deposition: 25/10/2020Map released: 11/11/2020
Last modified: 16/10/2024
Sample Organism:
Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 Spike Glycoprotein, prefusion with one RBD-up conformation
Fitted models: 7kj5
Deposition Authors: Zhang J
,
Xiao TS
Sample: SARS-CoV-2 Spike Glycoprotein, prefusion with one RBD-up conformation
Fitted models: 7kj5
Deposition Authors: Zhang J
,
Xiao TS
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent.
Xiao T ,
Lu J,
Zhang J ,
Johnson RI ,
McKay LGA ,
Storm N ,
Lavine CL,
Peng H,
Cai Y ,
Rits-Volloch S,
Lu S,
Quinlan BD,
Farzan M ,
Seaman MS,
Griffiths A,
Chen B
(2021) Nat Struct Mol Biol , 28 , 202 - 209
,
Lu J,
Zhang J ,
Johnson RI ,
McKay LGA ,
Storm N ,
Lavine CL,
Peng H,
Cai Y ,
Rits-Volloch S,
Lu S,
Quinlan BD,
Farzan M ,
Seaman MS,
Griffiths A,
Chen B
(2021) Nat Struct Mol Biol , 28 , 202 - 209
Grant Support:
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): AI147884 (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): AI147884 01A1S1 (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): AI141002 (United States)
- National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID): AI127193 (United States)